Insulin aspart, recombinant Subcutaneous and Pharmorubicin Pfs
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pharmorubicin Pfs and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: epirubicin
Brand name: Ellence, Pharmorubicin Pfs, Pharmorubicin RDF
Synonyms: Pharmorubicin Pfs (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Phazyme
- Insulin aspart, recombinant Subcutaneous-Phazyme Liquid Gas Relief, Maximum Strength
- Insulin aspart, recombinant Subcutaneous-Phena-Plus
- Insulin aspart, recombinant Subcutaneous-Phena-S
- Insulin aspart, recombinant Subcutaneous-Phenadoz
- Insulin aspart, recombinant Subcutaneous-Phenadoz rectal
- Pharmorubicin Pfs-Insulin degludec
- Pharmorubicin Pfs-Insulin Degludec (U-100) Prefilled Pens
- Pharmorubicin Pfs-Insulin Degludec (U-100) Vials
- Pharmorubicin Pfs-Insulin Degludec (U-200) Prefilled Pens
- Pharmorubicin Pfs-Insulin degludec and liraglutide
- Pharmorubicin Pfs-Insulin degludec and liraglutide Subcutaneous